Haemophilia trials in Austria

In Austria 11 Also abroad 128

11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Where
Innsbruck, Vienna
Age
12 years and over
People
360 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00
Phase 3Taking people
Efanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining
Where
Graz, Salzburg, Vienna
Age
18 years and over
People
60 worldwide
Run by
GWT-Tud GmbH
See details and how to join2025-523896-44-00 · EU 2025-523896-44-00
Phase 3Taking people
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Where
Wien
Age
1 year to 74 years
People
245 worldwide
Run by
Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Where
Vienna
Age
12 years and over
People
138 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00
Phase 3Taking people
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Where
Vienna
Age
138 months to 206 months
People
20 worldwide
Run by
CSL Behring
See details and how to joinNCT07080905 · EU 2023-505805-18-00
Phase 3Taking people
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Where
Vienna
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00
Phase 1Taking people
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Where
Innsbruck, Vienna
Age
18 years to 64 years
People
30 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07220564 · EU 2025-520490-38-00
No phaseEnrolling by invitation
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
Where
Vienna
People
60 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT03745924
No phaseTaking people
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Where
Vienna
Age
18 years and over
People
500 worldwide
Run by
CSL Behring
See details and how to joinNCT06008938
No phaseEnrolling by invitation
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
Where
Vienna
People
60 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT04574076
No phaseTaking people
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Where
Graz, Vienna
People
4,000 worldwide
Run by
PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119